US Stock MarketDetailed Quotes

NBRVF Nabriva Therapeutics PLC

Watchlist

0.000
0.0000.00%

15min DelayClose Jan 2 16:00 ET

3.23Market Cap0.00P/E (TTM)

Nabriva Therapeutics PLC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

103.92%511K

64.60%-5.62M

38.36%-36.71M

73.44%-1.63M

53.34%-6.18M

29.80%-13.04M

26.62%-15.87M

16.51%-59.56M

54.22%-6.12M

-5.11%-13.24M

Net income from continuing operations

-8.92%-12.06M

26.39%-8.7M

-15.64%-57.19M

-74.37%-22.78M

-8.09%-11.51M

5.79%-11.07M

15.46%-11.82M

28.83%-49.45M

26.75%-13.06M

17.75%-10.65M

Depreciation and amortization

-76.62%18K

-73.08%21K

-65.93%217K

-70.93%25K

-54.88%37K

-61.69%77K

-70.90%78K

-22.32%637K

-64.90%86K

-57.95%82K

Other non cash items

211.46%175K

37.97%367K

454.38%4.56M

925.65%4.32M

106.35%130K

-139.65%-157K

558.62%266K

9.89%822K

-12.47%421K

186.36%63K

Change In working capital

314.11%4.75M

131.42%1.7M

192.43%13.73M

194.40%16.68M

233.07%4.67M

73.05%-2.22M

38.53%-5.4M

-30.43%-14.86M

103.01%5.66M

-242.87%-3.51M

-Change in receivables

268.92%5.05M

-267.83%-3.86M

211.06%9.02M

140.26%6.57M

23.95%3.14M

65.80%-2.99M

149.48%2.3M

-37.88%-8.12M

203.21%2.74M

25,200.00%2.53M

-Change in inventory

1,442.27%1.5M

157.79%649K

155.64%4.83M

614.27%7.66M

67.12%-1.8M

108.52%97K

64.36%-1.12M

-68.96%-8.69M

5,460.00%1.07M

-800.82%-5.47M

-Change in payables and accrued expense

-327.09%-1.79M

180.98%5.03M

-87.07%326K

38.27%2.55M

959.95%3.2M

-56.57%790K

-708.59%-6.21M

325.29%2.52M

-59.58%1.84M

-39.85%-372K

-Change in other current assets

--0

-200.00%-1K

120.00%2K

---1K

--1K

-66.67%1K

107.69%1K

-225.00%-10K

--0

-Change in other current liabilities

132.73%127K

-1,007.14%-127K

----

---388K

106.93%14K

----

-Change in other working capital

----

21.59%-443K

-760.00%-99K

-19.40%-240K

--270K

---374K

-175.53%-565K

--15K

---201K

Cash from discontinued investing activities

Operating cash flow

103.92%511K

64.60%-5.62M

38.36%-36.71M

73.44%-1.63M

53.34%-6.18M

29.80%-13.04M

26.62%-15.87M

16.51%-59.56M

54.22%-6.12M

-5.11%-13.24M

Investing cash flow

Cash flow from continuing investing activities

56.90%-50K

91.67%-3K

-224.69%-263K

41.67%-7K

-104K

-327.45%-116K

70.00%-36K

70.44%-81K

29.41%-12K

Net PPE purchase and sale

--0

91.43%-3K

-744.00%-211K

-12.50%-9K

-10,400.00%-103K

-163.37%-64K

70.59%-35K

77.88%-25K

55.56%-8K

110.00%1K

Net other investing changes

----

7.14%-52K

150.00%2K

0.00%-1K

-4.00%-52K

0.00%-1K

65.22%-56K

-500.00%-4K

-200.00%-1K

Cash from discontinued investing activities

Investing cash flow

56.90%-50K

91.67%-3K

-224.69%-263K

41.67%-7K

---104K

-327.45%-116K

70.00%-36K

70.44%-81K

29.41%-12K

--0

Financing cash flow

Cash flow from continuing financing activities

-321.15%-4.85M

-97.21%1.85M

-130.82%-659K

-72.79%1.11M

-103.14%-792K

-93.72%2.19M

146.49%66.37M

-84.75%2.14M

9.02%4.07M

Net issuance payments of debt

--0

---4.85M

---2.92M

---998K

---974K

---949K

--0

Net common stock issuance

--0

-92.39%2.12M

--0

--77K

--403K

-93.55%1.64M

-47.79%27.91M

-82.97%2.45M

--0

Proceeds from stock option exercised by employees

----

---406K

--0

----

--0

Net other financing activities

--0

-99.82%1K

-92.06%3.06M

209.00%339K

-50.76%2.01M

-99.37%160K

-94.18%551K

1,295.32%38.46M

69.66%-311K

32.64%4.07M

Cash from discontinued financing activities

Financing cash flow

--0

-321.15%-4.85M

-97.21%1.85M

-130.82%-659K

-72.79%1.11M

-103.14%-792K

-93.72%2.19M

146.49%66.37M

-84.75%2.14M

9.02%4.07M

Net cash flow

Beginning cash position

-94.34%1.92M

-73.79%12.54M

15.01%47.83M

-71.69%14.77M

-67.12%20.16M

-38.28%33.96M

15.01%47.83M

-51.87%41.59M

26.17%52.17M

22.91%61.32M

Current changes in cash

103.31%461K

23.62%-10.47M

-622.04%-35.12M

42.61%-2.29M

43.57%-5.17M

-308.07%-13.95M

-204.00%-13.71M

115.06%6.73M

-723.75%-3.99M

-3.36%-9.17M

Effect of exchange rate changes

-183.55%-127K

12.80%-143K

64.05%-174K

117.24%60K

-1,157.14%-222K

137.91%152K

-167.21%-164K

-245.71%-484K

13.43%-348K

-93.67%21K

End cash Position

-88.82%2.26M

-94.34%1.92M

-73.79%12.54M

-71.69%14.77M

-67.12%20.16M

-38.28%33.96M

15.01%47.83M

26.17%52.17M

Free cash flow

103.90%511K

64.66%-5.62M

38.03%-36.92M

73.33%-1.63M

52.56%-6.28M

29.07%-13.1M

26.86%-15.91M

16.60%-59.58M

54.22%-6.13M

-5.02%-13.24M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	103.92%511K	64.60%-5.62M	38.36%-36.71M	73.44%-1.63M	53.34%-6.18M	29.80%-13.04M	26.62%-15.87M	16.51%-59.56M	54.22%-6.12M	-5.11%-13.24M
Net income from continuing operations	-8.92%-12.06M	26.39%-8.7M	-15.64%-57.19M	-74.37%-22.78M	-8.09%-11.51M	5.79%-11.07M	15.46%-11.82M	28.83%-49.45M	26.75%-13.06M	17.75%-10.65M
Depreciation and amortization	-76.62%18K	-73.08%21K	-65.93%217K	-70.93%25K	-54.88%37K	-61.69%77K	-70.90%78K	-22.32%637K	-64.90%86K	-57.95%82K
Other non cash items	211.46%175K	37.97%367K	454.38%4.56M	925.65%4.32M	106.35%130K	-139.65%-157K	558.62%266K	9.89%822K	-12.47%421K	186.36%63K
Change In working capital	314.11%4.75M	131.42%1.7M	192.43%13.73M	194.40%16.68M	233.07%4.67M	73.05%-2.22M	38.53%-5.4M	-30.43%-14.86M	103.01%5.66M	-242.87%-3.51M
-Change in receivables	268.92%5.05M	-267.83%-3.86M	211.06%9.02M	140.26%6.57M	23.95%3.14M	65.80%-2.99M	149.48%2.3M	-37.88%-8.12M	203.21%2.74M	25,200.00%2.53M
-Change in inventory	1,442.27%1.5M	157.79%649K	155.64%4.83M	614.27%7.66M	67.12%-1.8M	108.52%97K	64.36%-1.12M	-68.96%-8.69M	5,460.00%1.07M	-800.82%-5.47M
-Change in payables and accrued expense	-327.09%-1.79M	180.98%5.03M	-87.07%326K	38.27%2.55M	959.95%3.2M	-56.57%790K	-708.59%-6.21M	325.29%2.52M	-59.58%1.84M	-39.85%-372K
-Change in other current assets	--0	-200.00%-1K	120.00%2K	---1K	--1K	-66.67%1K	107.69%1K	-225.00%-10K	--0	--0
-Change in other current liabilities	132.73%127K	-1,007.14%-127K	----	----	----	---388K	106.93%14K	----	----	----
-Change in other working capital	----	----	21.59%-443K	-760.00%-99K	-19.40%-240K	--270K	---374K	-175.53%-565K	--15K	---201K
Cash from discontinued investing activities
Operating cash flow	103.92%511K	64.60%-5.62M	38.36%-36.71M	73.44%-1.63M	53.34%-6.18M	29.80%-13.04M	26.62%-15.87M	16.51%-59.56M	54.22%-6.12M	-5.11%-13.24M
Investing cash flow
Cash flow from continuing investing activities	56.90%-50K	91.67%-3K	-224.69%-263K	41.67%-7K	-104K	-327.45%-116K	70.00%-36K	70.44%-81K	29.41%-12K	0
Net PPE purchase and sale	--0	91.43%-3K	-744.00%-211K	-12.50%-9K	-10,400.00%-103K	-163.37%-64K	70.59%-35K	77.88%-25K	55.56%-8K	110.00%1K
Net other investing changes	----	----	7.14%-52K	150.00%2K	0.00%-1K	-4.00%-52K	0.00%-1K	65.22%-56K	-500.00%-4K	-200.00%-1K
Cash from discontinued investing activities
Investing cash flow	56.90%-50K	91.67%-3K	-224.69%-263K	41.67%-7K	---104K	-327.45%-116K	70.00%-36K	70.44%-81K	29.41%-12K	--0
Financing cash flow
Cash flow from continuing financing activities	0	-321.15%-4.85M	-97.21%1.85M	-130.82%-659K	-72.79%1.11M	-103.14%-792K	-93.72%2.19M	146.49%66.37M	-84.75%2.14M	9.02%4.07M
Net issuance payments of debt	--0	---4.85M	---2.92M	---998K	---974K	---949K	--0	--0	--0	--0
Net common stock issuance	--0	--0	-92.39%2.12M	--0	--77K	--403K	-93.55%1.64M	-47.79%27.91M	-82.97%2.45M	--0
Proceeds from stock option exercised by employees	----	----	---406K	--0	--0	----	----	--0	--0	--0
Net other financing activities	--0	-99.82%1K	-92.06%3.06M	209.00%339K	-50.76%2.01M	-99.37%160K	-94.18%551K	1,295.32%38.46M	69.66%-311K	32.64%4.07M
Cash from discontinued financing activities
Financing cash flow	--0	-321.15%-4.85M	-97.21%1.85M	-130.82%-659K	-72.79%1.11M	-103.14%-792K	-93.72%2.19M	146.49%66.37M	-84.75%2.14M	9.02%4.07M
Net cash flow
Beginning cash position	-94.34%1.92M	-73.79%12.54M	15.01%47.83M	-71.69%14.77M	-67.12%20.16M	-38.28%33.96M	15.01%47.83M	-51.87%41.59M	26.17%52.17M	22.91%61.32M
Current changes in cash	103.31%461K	23.62%-10.47M	-622.04%-35.12M	42.61%-2.29M	43.57%-5.17M	-308.07%-13.95M	-204.00%-13.71M	115.06%6.73M	-723.75%-3.99M	-3.36%-9.17M
Effect of exchange rate changes	-183.55%-127K	12.80%-143K	64.05%-174K	117.24%60K	-1,157.14%-222K	137.91%152K	-167.21%-164K	-245.71%-484K	13.43%-348K	-93.67%21K
End cash Position	-88.82%2.26M	-94.34%1.92M	-73.79%12.54M	-73.79%12.54M	-71.69%14.77M	-67.12%20.16M	-38.28%33.96M	15.01%47.83M	15.01%47.83M	26.17%52.17M
Free cash flow	103.90%511K	64.66%-5.62M	38.03%-36.92M	73.33%-1.63M	52.56%-6.28M	29.07%-13.1M	26.86%-15.91M	16.60%-59.58M	54.22%-6.13M	-5.02%-13.24M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Heat List

Overall

No Data